The Global Cardiac Implants Market size is expected to grow from USD 6.8 billion in 2018 to USD 10.3 billion by 2028, at a CAGR of 7.5% during the forecast period (2021-2028). The growth of this market can be attributed to factors such as increased awareness related to heart ailments and the increasing geriatric population, growing incidence rates for cardiovascular diseases, and improved technological advancements in devices used for cardiac surgeries.
Cardiac Implants are used to replace faulty heart valves or any other part of the heart. The implants help in treating cardiogenic shock, congestive heart failure, and chronic obstructive pulmonary disease (COPD), which are common diseases associated with a high risk of death rates. Cardiovascular problems can be fatal if not treated on time so Cardiac Implant devices are a great alternative for people who fail traditional treatments like bypass surgery or open-heart surgery. Cardiac Implants are used to replace or support human tissue in patients with cardiomyopathy, congestive heart failure, congenital defects such as ventricular septal defect (VSD), atrial septal defect (ASD), tetralogy of Fallot, etc.
On the basis of Type, the market is segmented into Cardiac Implants, Coronary Stent Devices, Prosthetic Heart Valves, and Cardiac Assist Devices. The Prosthetic Heart Valves segment accounted for the largest share in 2018 of around 20% followed by Cardiac Implants with 19%.
Cardiac Implants are devices that are implanted inside the body, during a surgical procedure. Cardiac Implants fulfill some of the critical functions of an organ and assist in a person's day-to-day life by replacing or augmenting damaged heart valves, cardiac catheters, etc. Implantation may be necessary to treat various conditions such as congestive heart failure, valve disease with stenosis (most common cause), endocarditis, and congenital abnormalities in infants among others.
Coronary stents are small, metal mesh tubes with a balloon on the end that is placed in an artery of someone who has experienced heart disease. Coronary Stent Devices include coronary angioplasty balloons and wire-mesh scaffolds or grafts used to hold open blocked arteries. These devices are implanted through catheterization procedures during surgery or at intervals throughout one's life to widen narrowed coronary blood vessels that have been damaged by atherosclerosis (thickening of arterial walls to improve the flow of oxygenated blood from both sides of the heart).
The prosthetic heart valve is an artificial valve that replaces a diseased or damaged natural valve. The artificial valves are made of either plastic, metal, and/or animal tissue. They are implanted into the patient's existing blood vessel so they can regulate the flow of oxygenated blood from one chamber to another. Cardiology patients who have undergone open-heart surgery often need this type of surgery because their coronary artery was not repaired during cardiac bypass operation and there is less than 90% function in one or more chambers as a result.
Cardiac Assist Devices is a market segment for cardiac implant products which provide circulatory assistance by mimicking natural left-to-right blood flow from the right side of the heart to both sides of the body when it can’t do so on its own. In addition, cardiomyoplasty is also considered an application under this category. These procedures involve repairing damaged tissues around the heart using grafts taken from another part of one's own body - such as fat tissue harvested through liposuction - along with synthetic mesh constructs.
Cardiac Assist Devices are used to assist the heart in pumping blood throughout the body. They are quite rare, and often only acquired for use when a patient's heart can no longer function on its own with any effectiveness. Cardiac Assist Devices do not replace the heart entirely though; they just provide assistance that is needed while awaiting transplantation of a new organ or recovery from surgery.
On the basis of Application, the market is segmented into Hospital Pharmacies (including ambulatory care), Retail Pharmacies, Drug Stores, Online Sales, and Others. The Others application type accounted for a significant share at 60% as it includes older people who are on medications like beta-blockers which can be taken without medical supervision or patients who need to take anticoagulant drugs such as warfarin before surgery. This category also includes traveling professionals looking for medicines abroad where they are not readily available or the cost of medication is much lower. The online sales of cardiac implants are increasing due to the convenience offered in ordering products from home or office environments.
On the basis of Region, the market is segmented into North America, Europe, Asia Pacific, and Middle East & Africa.
North America: North American Cardiac Implants Market is segmented into Canada, Mexico, and United States. The US dominates the market with a share of over 34% in 2018. The country has registered an increase in the prevalence of cardiovascular diseases coupled with the development of advanced healthcare infrastructure for treatment thereof which are expected to drive demand for cardiac implants at elevated levels from 2020 onwards.
Europe: European Cardiac Implants Market is segmented into Germany, France, Italy, and the UK. The region dominated the global market with a share exceeding 45% in 2018 owing to continuous innovation in medical technology associated with cardiology as well as high per capita expenditure on health care services across Europe which will remain favorable towards adoption till 2028.
Asia Pacific: Asia- Pacific Cardiac Implants Market is segmented into China, Japan, and India. The region was the fastest-growing regional market in 2018 owing to the rising prevalence of cardiovascular diseases coupled with the development of advanced healthcare infrastructure for treatment thereof which will enhance demand at elevated levels from 2020 onwards.
Latin America: Latin American Cardiac Implants Market is segmented into Brazil, Mexico, and Argentina. The region has registered an increase in prevalence owing to non-communicable diseases such as hypertension, diabetes, and obesity.
Up Market Research published a new report titled “Cardiac Implants Market research report which is segmented by Types (Cardiac Implants, Coronary Stent Devices, Prosthetic Heart Valves, Cardiac Assist Devices), By Applications (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Sales), By Players/Companies Medtronic, Boston Scientific, Abbott Vascular, Edwards, St.Jude Medical, Thoratec, SynCardia”.
|Report Attributes||Report Details|
|Report Title||Cardiac Implants Market Research Report|
|By Type||Cardiac Implants, Coronary Stent Devices, Prosthetic Heart Valves, Cardiac Assist Devices|
|By Application||Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Sales|
|By Companies||Medtronic, Boston Scientific, Abbott Vascular, Edwards, St.Jude Medical, Thoratec, SynCardia|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||205|
|Number of Tables & Figures||144|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Cardiac Implants, Coronary Stent Devices, Prosthetic Heart Valves, Cardiac Assist Devices and By Application Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Sales.
Some of the companies that are profiled in this report are:
Cardiac Implants Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Cardiac Implants Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Cardiac Implants Market Report:
Some other reports from this category!